Galectin Therapeutics (GALT) Return on Capital Employed Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4,853.00 |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | 26,296.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,296.00 |
| Dec 31, 2025 | 33,631.00 |
| Sep 30, 2025 | 30,930.00 |
| Jun 30, 2025 | -171,227.00 |
| Mar 31, 2025 | 16,171.00 |
| Dec 31, 2024 | 44,618.00 |
| Sep 30, 2024 | -118,337.00 |
| Jun 30, 2024 | -19,839.00 |
| Mar 31, 2024 | -13,808.00 |
| Dec 31, 2023 | -31,181.00 |
| Sep 30, 2023 | -31,018.00 |
| Jun 30, 2023 | -32,739.00 |
| Mar 31, 2023 | -38,770.00 |
| Dec 31, 2022 | -55,348.00 |
| Sep 30, 2022 | -26,327.00 |
| Jun 30, 2022 | -14,903.00 |
| Mar 31, 2022 | 3,708.00 |
| Dec 31, 2021 | 7,891.00 |
| Sep 30, 2021 | 2,864.00 |
| Jun 30, 2021 | 9,397.00 |
| Mar 31, 2021 | 56,273.00 |
| Dec 31, 2020 | 53,187.00 |
| Sep 30, 2020 | 42,335.00 |
| Jun 30, 2020 | 18,200.00 |
| Mar 31, 2020 | 15,360.00 |
| Dec 31, 2019 | 14,772.00 |
| Sep 30, 2019 | 14,252.00 |
| Jun 30, 2019 | 9,783.00 |
| Mar 31, 2019 | -5,368.00 |
| Dec 31, 2018 | -8,774.00 |
| Mar 31, 2018 | -62,994.00 |
| Dec 31, 2017 | -56,700.00 |
| Sep 30, 2017 | -43,653.00 |
| Jun 30, 2017 | -18,479.00 |
| Mar 31, 2017 | -12,336.00 |
| Dec 31, 2016 | -2,044.00 |
| Sep 30, 2016 | 3,337.00 |
| Jun 30, 2016 | 9,806.00 |
| Mar 31, 2016 | 5,810.00 |
| Dec 31, 2015 | 2,443.00 |
| Mar 31, 2015 | 6,170.00 |
| Dec 31, 2014 | 14,883.00 |
| Sep 30, 2014 | 6,788.00 |